MedPath

TODACITAN 1,5 MG COMPRIMIDOS EFG

TODACITAN 1,5 MG COMPRIMIDOS EFG

Commercialized
Register Number

24354IP3

Prescription Type

Medicamento Sujeto A Prescripción Médica

Authorization Date

May 27, 2025

Dosage Form

COMPRIMIDO

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number24354IP3
EMA Approved
No

Drug Classification

Generic
Yes
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

CITISINAActive
Quantity: 1,5 mg
Name: CITISINA

ATC CLASSIFICATION (3)

N07B
N07BA
N07BA04

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.